ID   COLO 349
AC   CVCL_X385
SY   COLO #349; Colorado 349
DR   Wikidata; Q54814097
RX   PubMed=6174766;
RX   PubMed=6277475;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HR ! COLO 342
OI   CVCL_E5HS ! COLO 343
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
RX   PubMed=6174766; DOI=10.1093/jnci/68.3.365;
RA   Semple T.U., Moore G.E., Morgan R.T., Woods L.K., Quinn L.A.;
RT   "Multiple cell lines from patients with malignant melanoma:
RT   morphology, karyology, and biochemical analysis.";
RL   J. Natl. Cancer Inst. 68:365-380(1982).
//
RX   PubMed=6277475;
RA   Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E.,
RA   Moseley J.M., Martin T.J.;
RT   "Presence of 1,25-dihydroxyvitamin D3 receptors in established human
RT   cancer cell lines in culture.";
RL   Cancer Res. 42:1116-1119(1982).
//
RX   PubMed=6349783; DOI=10.1002/1097-0142(19830915)52:6<949::AID-CNCR2820520602>3.0.CO;2-2;
RA   Dantas M.E., Brown J.P., Thomas M.R., Robinson W.A., Glode L.M.;
RT   "Detection of melanoma cells in bone marrow using monoclonal
RT   antibodies. A comparison of fluorescence activated cell sorting (FACS)
RT   and conventional immunofluorescence (IF).";
RL   Cancer 52:949-953(1983).
//